Rezultati pretraživanja
  1. prije 41 sekundu

    Rush Limbaugh redefined the Medal of freedom

  2. prije 18 minuta

    Whatever Chinese may offer to (if anything, they already patenting as their own) will not move the needle on 85B stock, going long GILD here especially after disappointing earnings last night is purely emotional and very risky trade

    1 korisnik označava da mu se sviđa
  3. prije 1 sat

    Looks like Chinese will just take GILD's drug and say thank you! GILD shipped 200kg of this drug to China and Chinese already patenting this drug as their own for use in China, unbelievable! Not sure shareholders will benefit much here

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
  4. prije 2 sata

    Got a few QQQ 230$14 FEB Calls at 10.10 am.A new leg up underway,target 235 by 14 feb.

    1 korisnik označava da mu se sviđa
  5. prije 2 sata

    To the moon & beyond!

  6. prije 3 sata

    Top 5 ETFs in February 6.92% Palladium 4.49% South Korea 4.28% Semiconductors 4.16% Biotech 3.98% Technology 3.90% Materials

    1 korisnik označava da mu se sviđa
  7. prije 7 sati

    Goooooooooooood morning fam 🌄🌄🌄🌄🌄 Welcome to Gain city we can only help you so much this was a gift dip of a life time hope u guys made some gains

    2 korisnika označavaju da im se sviđa
  8. prije 11 sati

    quickly reaching target after breaking out of descending wedge.💪

    2 korisnika označavaju da im se sviđa
  9. prije 12 sati

    new all time highs

    2 korisnika označavaju da im se sviđa
  10. prije 12 sati

    **UPDATE** clinical stage bio hitting new all time highs

    Prikaži ovu nit
    Prikaži ovu nit
  11. prije 19 sati

    Mish’s Daily: Market Be Like Standing on a Galloping Horse.

  12. prije 19 sati

    URO-902 Gene Therapy in Patients with Overactive Bladder Phase 1 Data Publication Announced. Find URO-902 and Vibegron Prior/Upcoming Data Here:

  13. prije 21 sat

    Regeneron shares jumped over 5% after the company said it is investigating the monoclonal antibody treatment REGN-EB3, also known as REGN3470-3471-3479, for novel , 2019-nCoV. This is not a BUY/SELL recommendation.

  14. prije 22 sata

    Path 2 Prosperity I'm being told to buy Corbus

    Experts recently discussed the therapeutic potential of targeting the endocannabinoid system. Live webcast replay of the symposium hosted by is now available:
    3 korisnika označavaju da im se sviđa
  15. 4. velj

    back on track , we could see good events ahead. Still very cheap could hit $20 in the short term before some bids

    1 reply 1 proslijeđeni tweet 2 korisnika označavaju da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
  16. 4. velj

    Net fund flows down by ~$23 million for last week. down by ~$192 million over the same period. Net fund flows for Biotech ETFs for last week (with minimal participation from medtech, medical equipment, pharma, PBMs, consolidated healthcare etc).

  17. 4. velj

    weekly 115-120 longer calls same strikes imho

    1 korisnik označava da mu se sviđa
  18. 3. velj

    fights back

  19. 3. velj

    Mahommes throw deflect by someones helmet and caught by

    1 korisnik označava da mu se sviđa

Nema rezultata.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.